Climb Bio, Inc. (CLYM)
10.80
-0.14
(-1.28%)
USD |
NASDAQ |
Oct 05, 09:53
Climb Bio EPS Diluted (Quarterly) : -0.1772 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1772 |
| March 31, 2026 | -0.2012 |
| December 31, 2025 | -0.26 |
| September 30, 2025 | -0.1895 |
| June 30, 2025 | -0.1282 |
| March 31, 2025 | -0.308 |
| December 31, 2024 | -0.1251 |
| September 30, 2024 | -0.1327 |
| June 30, 2024 | -1.809 |
| March 31, 2024 | -0.0614 |
| December 31, 2023 | -0.1314 |
| September 30, 2023 | -0.1466 |
| June 30, 2023 | -0.1945 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.8414 |
| December 31, 2022 | -0.2943 |
| September 30, 2022 | -0.3676 |
| June 30, 2022 | -0.555 |
| March 31, 2022 | -0.497 |
| December 31, 2021 | -0.4019 |
| September 30, 2021 | -0.4174 |
| June 30, 2021 | -0.4091 |
| March 31, 2021 | -0.748 |
| September 30, 2020 | -0.1038 |
| June 30, 2020 | -0.0792 |
| March 31, 2020 | -0.0895 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -2.890 |
| Cullinan Therapeutics, Inc. | -0.8666 |
| Q32 Bio, Inc. | -0.4398 |
| Artiva Biotherapeutics, Inc. | -0.6344 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.50M |
| Total Expenses (Quarterly) | 13.50M |
| Enterprise Value | 446.54M |
| Earnings Yield | -7.67% |
| Normalized Earnings Yield | -7.666 |